NO20030034L - En kombinasjon av FBPase-inhibitorer og antidiabetiske midler anvendbare for behandling av diabetes - Google Patents
En kombinasjon av FBPase-inhibitorer og antidiabetiske midler anvendbare for behandling av diabetesInfo
- Publication number
- NO20030034L NO20030034L NO20030034A NO20030034A NO20030034L NO 20030034 L NO20030034 L NO 20030034L NO 20030034 A NO20030034 A NO 20030034A NO 20030034 A NO20030034 A NO 20030034A NO 20030034 L NO20030034 L NO 20030034L
- Authority
- NO
- Norway
- Prior art keywords
- diabetes
- treatment
- combination
- agents useful
- antidiabetic agents
- Prior art date
Links
- 101710099475 3'-phosphoadenosine 5'-phosphate phosphatase Proteins 0.000 title 1
- 101710196411 Fructose-1,6-bisphosphatase Proteins 0.000 title 1
- 101710186733 Fructose-1,6-bisphosphatase, chloroplastic Proteins 0.000 title 1
- 101710109119 Fructose-1,6-bisphosphatase, cytosolic Proteins 0.000 title 1
- 101710198902 Fructose-1,6-bisphosphate aldolase/phosphatase Proteins 0.000 title 1
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 229940125708 antidiabetic agent Drugs 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21653100P | 2000-07-06 | 2000-07-06 | |
| PCT/US2001/021557 WO2002003978A2 (fr) | 2000-07-06 | 2001-07-05 | Combinaison d'inhibiteurs de fbpase et d'agents antidiabetiques utile pour le traitement du diabete |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030034D0 NO20030034D0 (no) | 2003-01-03 |
| NO20030034L true NO20030034L (no) | 2003-03-05 |
Family
ID=22807416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030034A NO20030034L (no) | 2000-07-06 | 2003-01-03 | En kombinasjon av FBPase-inhibitorer og antidiabetiske midler anvendbare for behandling av diabetes |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1372660A2 (fr) |
| JP (1) | JP2004508297A (fr) |
| KR (1) | KR100854851B1 (fr) |
| CN (2) | CN101301294A (fr) |
| AU (2) | AU2001273271B2 (fr) |
| BR (1) | BR0112212A (fr) |
| CA (1) | CA2412142A1 (fr) |
| CZ (1) | CZ20035A3 (fr) |
| HU (1) | HUP0301830A3 (fr) |
| IL (2) | IL153513A0 (fr) |
| MX (1) | MXPA02012713A (fr) |
| NO (1) | NO20030034L (fr) |
| NZ (1) | NZ523227A (fr) |
| PL (1) | PL365779A1 (fr) |
| RU (1) | RU2328308C2 (fr) |
| SK (1) | SK62003A3 (fr) |
| WO (1) | WO2002003978A2 (fr) |
| ZA (1) | ZA200300044B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6284748B1 (en) | 1997-03-07 | 2001-09-04 | Metabasis Therapeutics, Inc. | Purine inhibitors of fructose 1,6-bisphosphatase |
| NZ510308A (en) | 1998-09-09 | 2003-06-30 | Metabasis Therapeutics Inc | Heteroaromatic alkylene substituted phosphonate derivatives useful as inhibitors of Fructose 1,6-bisphosphatase |
| CZ20023018A3 (cs) | 2000-03-08 | 2003-01-15 | Metabasis Therapeutics, Inc. | Nové inhibitory fruktóza-1,6-bisfosfatázy obsahující arylovou skupinu |
| US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| JP2005508324A (ja) | 2001-09-24 | 2005-03-31 | インペリアル カレッジ イノベーションズ リミテッド | 摂食行動の修正 |
| EP1474163A2 (fr) | 2002-01-10 | 2004-11-10 | Imperial College Innovations Limited | Modification des habitudes alimentaires |
| GB0300571D0 (en) | 2003-01-10 | 2003-02-12 | Imp College Innovations Ltd | Modification of feeding behaviour |
| PL3002283T3 (pl) | 2003-12-26 | 2017-10-31 | Kyowa Hakko Kirin Co Ltd | Pochodne tiazolu |
| JP2008510018A (ja) * | 2004-08-18 | 2008-04-03 | メタバシス・セラピューティクス・インコーポレイテッド | フルクトース−１，６−ビスホスファターゼの新規チアゾール阻害物質 |
| US20070259928A1 (en) * | 2004-12-13 | 2007-11-08 | Taishi Yoshida | Medicinal Composition for Treating Diabetes |
| TW200738245A (en) * | 2005-08-22 | 2007-10-16 | Sankyo Co | Pharmaceutical composition containing FBPase inhibitor |
| WO2007129522A1 (fr) * | 2006-04-10 | 2007-11-15 | Daiichi Sankyo Company, Limited | Préparation obtenue par voie sèche |
| US20100222304A1 (en) | 2006-11-02 | 2010-09-02 | Lillian W Chiang | Methods of Treating Neuropathic Pain by Modulation of Glycogenolysis or Glycolysis |
| TWI428346B (zh) | 2006-12-13 | 2014-03-01 | Imp Innovations Ltd | 新穎化合物及其等對進食行為影響 |
| CN107312039B (zh) | 2012-08-30 | 2019-06-25 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药的制备方法 |
| TWI606848B (zh) * | 2012-10-08 | 2017-12-01 | Ｌｇ生命科學股份有限公司 | 包含格米列汀與美氟明的組合藥物及其製備方法 |
| CN104788350A (zh) * | 2014-01-22 | 2015-07-22 | 天津大学 | 一种通过快速冷却结晶法获得甲糖宁药用优势晶型的方法 |
| CN106831437B (zh) * | 2016-02-03 | 2019-06-21 | 华中师范大学 | 含硝基乙烯基的酯类化合物及其制备方法和应用 |
| CN114907285B (zh) * | 2021-02-10 | 2023-09-22 | 华中师范大学 | 酰化糖精类化合物及其制备方法和应用、降血糖药物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE75372B1 (en) * | 1989-01-24 | 1997-09-10 | Gensia Pharma | Method and compounds for AICA riboside delivery and for lowering blood glucose |
| US6284748B1 (en) * | 1997-03-07 | 2001-09-04 | Metabasis Therapeutics, Inc. | Purine inhibitors of fructose 1,6-bisphosphatase |
| WO1998039342A1 (fr) * | 1997-03-07 | 1998-09-11 | Metabasis Therapeutics, Inc. | Nouveaux composes d'indole et d'azaindole inhibiteurs de fructose-1,6-biophosphatase |
| PT970095E (pt) * | 1997-03-07 | 2004-03-31 | Metabasis Therapeutics Inc | Novos inibidores benzimidazole de frutose-1,6-bisfosfatase |
| CA2289621A1 (fr) * | 1998-03-16 | 1999-09-23 | Ontogen Corporation | Piperazines utilisees en tant qu'inhibiteurs de fructose-1,6-bisphosphatase (fbpase) |
| NZ510308A (en) * | 1998-09-09 | 2003-06-30 | Metabasis Therapeutics Inc | Heteroaromatic alkylene substituted phosphonate derivatives useful as inhibitors of Fructose 1,6-bisphosphatase |
| CN1714866A (zh) * | 1998-12-24 | 2006-01-04 | 症变治疗公司 | 治疗糖尿病的fbp酶抑制剂与胰岛素致敏剂的组合 |
| DK1743655T3 (da) * | 2000-01-21 | 2014-08-18 | Novartis Ag | Kombinationer omfattende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler |
| GB0015627D0 (en) * | 2000-06-26 | 2000-08-16 | Rademacher Group Limited | Phosphoglycan messengers and their medical uses |
-
2001
- 2001-07-05 AU AU2001273271A patent/AU2001273271B2/en not_active Ceased
- 2001-07-05 PL PL01365779A patent/PL365779A1/xx unknown
- 2001-07-05 RU RU2003103436/15A patent/RU2328308C2/ru not_active IP Right Cessation
- 2001-07-05 BR BR0112212-6A patent/BR0112212A/pt not_active IP Right Cessation
- 2001-07-05 AU AU7327101A patent/AU7327101A/xx active Pending
- 2001-07-05 MX MXPA02012713A patent/MXPA02012713A/es not_active Application Discontinuation
- 2001-07-05 SK SK6-2003A patent/SK62003A3/sk unknown
- 2001-07-05 WO PCT/US2001/021557 patent/WO2002003978A2/fr active IP Right Grant
- 2001-07-05 CZ CZ20035A patent/CZ20035A3/cs unknown
- 2001-07-05 NZ NZ523227A patent/NZ523227A/en not_active IP Right Cessation
- 2001-07-05 CN CNA200810098112XA patent/CN101301294A/zh active Pending
- 2001-07-05 CA CA002412142A patent/CA2412142A1/fr not_active Abandoned
- 2001-07-05 CN CNB018149243A patent/CN100396283C/zh not_active Expired - Fee Related
- 2001-07-05 IL IL15351301A patent/IL153513A0/xx unknown
- 2001-07-05 JP JP2002508433A patent/JP2004508297A/ja active Pending
- 2001-07-05 EP EP01952530A patent/EP1372660A2/fr not_active Withdrawn
- 2001-07-05 KR KR1020037000126A patent/KR100854851B1/ko not_active Expired - Fee Related
- 2001-07-05 HU HU0301830A patent/HUP0301830A3/hu unknown
-
2002
- 2002-12-18 IL IL153513A patent/IL153513A/en not_active IP Right Cessation
-
2003
- 2003-01-02 ZA ZA200300044A patent/ZA200300044B/en unknown
- 2003-01-03 NO NO20030034A patent/NO20030034L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2328308C2 (ru) | 2008-07-10 |
| MXPA02012713A (es) | 2004-09-10 |
| CZ20035A3 (cs) | 2003-05-14 |
| HUP0301830A3 (en) | 2007-10-29 |
| KR100854851B1 (ko) | 2008-08-27 |
| PL365779A1 (en) | 2005-01-10 |
| NZ523227A (en) | 2005-04-29 |
| NO20030034D0 (no) | 2003-01-03 |
| HUP0301830A2 (hu) | 2003-11-28 |
| BR0112212A (pt) | 2003-12-30 |
| JP2004508297A (ja) | 2004-03-18 |
| IL153513A (en) | 2014-07-31 |
| CN1599612A (zh) | 2005-03-23 |
| AU2001273271B2 (en) | 2006-01-05 |
| CN100396283C (zh) | 2008-06-25 |
| KR20030031952A (ko) | 2003-04-23 |
| CN101301294A (zh) | 2008-11-12 |
| CA2412142A1 (fr) | 2002-01-17 |
| ZA200300044B (en) | 2004-05-06 |
| WO2002003978A3 (fr) | 2003-10-16 |
| EP1372660A2 (fr) | 2004-01-02 |
| AU7327101A (en) | 2002-01-21 |
| WO2002003978A2 (fr) | 2002-01-17 |
| IL153513A0 (en) | 2003-07-06 |
| SK62003A3 (en) | 2003-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030034D0 (no) | En kombinasjon av FBPase inhibitorer og antidiabetiske midler anvendbare for behandling av diabetes | |
| IS6700A (is) | Meðferðarblanda CETP hindra og atórvastatíns | |
| NO20032668D0 (no) | Gyraseinhibitorer og anvendelser derav | |
| NO20022656L (no) | Caspaseinhibitorer og anvendelse derav | |
| DK1251848T3 (da) | Gyraseinhibitorer og anvendelse deraf | |
| CY2008010I2 (el) | Ενωσεις που περιλαμβανουν αναστολεις διπεπτυδυλοπεπτιδασης-iv και αντιδιαβητικους παραγοντες | |
| NO20020343D0 (no) | Kaspase-inhibitorer og anvendelse derav | |
| NO20042229L (no) | Type 4-fosfodiestemseinhibitorer og anvendelse derav | |
| NO20016314D0 (no) | Blandinger og fremgangsmåte for oljefeltapplikasjoner | |
| NO20011114D0 (no) | FremgangsmÕte og anordning for brudd-/gruspakker | |
| IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
| NO20022086D0 (no) | Antidiabetisk formulering og fremgangsmåte | |
| NO20014823D0 (no) | Heterocyklus-holdige bifenyl-aP2-inhibitorer og metode | |
| DK1339292T3 (da) | Sammensætning og fremgangsmåde | |
| PL374598A1 (en) | Caspase inhibitors and uses thereof | |
| AU2002361861A8 (en) | Selective 11beta-hsd inhibitors and methods for use thereof | |
| EP1337255A4 (fr) | Utilisation d'inhibiteurs p38 pour le traitement de toux inflammatoire | |
| DK1322597T3 (da) | Fremgangsmåde og intermediære | |
| AU2003232848A8 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
| GB0003254D0 (en) | Heterocyclic compounds and their therapeutic use | |
| IS7275A (is) | Samsetning fyrir hollegg og notkun á henni | |
| IL158395A0 (en) | Aromatase inhibitor for use in reproduction | |
| DE60106740D1 (de) | Hydrazid und alkoxyamid angiogeneseinhibitoren | |
| NO20026065L (no) | Prosesser for måling av dinofysistoksin og av yessotoksin | |
| NO20032821D0 (no) | Sea-trosy og beslektede fremgangsmåter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |